Equities / Sectors / Healthcare
Healthcare
#6 by market capPharmaceuticals, biotechnology, medical devices and care providers. 565 US-listed equities across 10 industries; the sector accounts for 9.4% of tracked equity market cap and 11.2% of daily volume.
Market cap
$7.832T
+1.66%
$128.102B · 1D
Sector weight
9.4%
of tracked market cap
Volume 24h
$2.467B
11.2% of market volume
Revenue TTM
$4.184T
Sum of constituents
Net income TTM
$153.576B
3.7% net margin
P/E (TTM)
50.7×
Market 30.6×
Dividend yield
1.7%
Market 1.3%
Employees
4.4M
Across 565 companies
Industry breakdown
Share of sector market cap · 10 industries
Concentration
Share of sector market cap by constituent
HHI index
392.3
Mega caps
7
Median cap
$1.402B
Valuation vs. market
Sector totals valued as one company; marker is the all-equities median
P/E (TTM): 50.7× · market 20.1×
P/S: 1.9× · market 2.7×
EV / EBITDA: 19.5× · market 13×
Operating margin: 7.9% · market 8.5%
Dividend yield: 1.7% · market 2.3%
Trading at a 65.7% P/E premium to the all-equities market.
Returns vs. market
Cap-weighted price return · spread in percentage points
| Period | Sector | Market | Spread |
|---|---|---|---|
| 1 day | +1.66% | +0.57% | +1.10% |
| 1 week | +2.27% | +1.93% | +0.33% |
| 1 month | +1.28% | +1.08% | +0.20% |
| 3 months | +3.42% | +2.36% | +1.07% |
| Year to date | +10.75% | +13.01% | -2.26% |
| 1 year | +19.09% | +14.14% | +4.95% |
Constituents
565 equities
Eli Lilly and Company LLY · US | Drug Manufacturers - General | $1.045T | 13.3% | $1.17K | +0.27% | +1.99% | +4.34% | $24.52M | 39.1× |
Johnson & Johnson JNJ · US | Drug Manufacturers - General | $627.343B | 8% | $260.50 | +1.57% | +0.71% | -3.20% | $26.48M | 29.8× |
AbbVie Inc. ABBV · US | Drug Manufacturers - General | $489.284B | 6.2% | $276.89 | +1.64% | +6.53% | +11.30% | $16.47M | 78.1× |
Merck & Co., Inc. MRK · US | Drug Manufacturers - General | $359.081B | 4.6% | $145.40 | +2.12% | +1.11% | -2.06% | $42.6M | 40.2× |
UnitedHealth Group Inc. UNH · US | Healthcare Plans | $341.04B | 4.4% | $376.84 | +1.59% | +3.19% | -5.99% | $92.93M | 24.2× |
Thermo Fisher Scientific Inc. TMO · US | Diagnostics & Research | $244.755B | 3.1% | $658.62 | +1.02% | +0.94% | +9.22% | $28.82M | 35.8× |
Amgen Inc. Common Stock AMGN · US | Drug Manufacturers - General | $223.535B | 2.9% | $413.50 | +1.49% | +1.53% | +5.17% | $22.63M | 25.6× |
Gilead Sciences, Inc. GILD · US | Drug Manufacturers - General | $187.044B | 2.4% | $150.72 | +2.46% | +2.18% | +2.78% | $17.39M | -57.7× |
Abbott Laboratories ABT · US | Medical Devices | $173.589B | 2.2% | $99.66 | +1.19% | +3.07% | -5.55% | $17.04M | 27.7× |
Pfizer Inc. PFE · US | Drug Manufacturers - General | $160.199B | 2% | $28.11 | +1.04% | -0.04% | +1.15% | $25.29M | 21.4× |
Danaher Corp. DHR · US | Diagnostics & Research | $154.041B | 2% | $219.15 | +0.78% | +3.49% | +6.78% | $15.12M | 38.5× |
Intuitive Surgical Inc. ISRG · US | Medical Instruments & Supplies | $149.535B | 1.9% | $422.54 | +1.72% | +5.31% | +20.67% | $20.2M | 47.6× |
| Biotechnology | $129.182B | 1.6% | $509.90 | +1.32% | +0.62% | -3.59% | $15.3M | 29.3× | |
Bristol-Myers Squibb Company BMY · US | Drug Manufacturers - General | $121.626B | 1.6% | $59.57 | -0.02% | -3.08% | -7.92% | $13.23M | 13.1× |
McKesson Corporation MCK · US | Medical Distribution | $112.385B | 1.4% | $936.54 | +0.68% | +4.20% | +5.33% | $8.13M | 23.6× |
Medtronic plc MDT · US | Medical Devices | $112.337B | 1.4% | $87.76 | +0.01% | +1.53% | -5.01% | $162.61M | 21.5× |
CVS Health Corporation Common Stock CVS · US | Healthcare Plans | $111.448B | 1.4% | $87.21 | -0.68% | +2.36% | -9.22% | $40.36M | 22.8× |
Stryker Corp. SYK · US | Medical Devices | $106.873B | 1.4% | $278.63 | +0.60% | +2.08% | +0.80% | $10.46M | 28.7× |
HCA Healthcare, Inc. HCA · US | Medical Care Facilities | $97.482B | 1.2% | $447.24 | +0.50% | +5.63% | +11.25% | $7.5M | 14.3× |
Elevance Health, Inc. ELV · US | Healthcare Plans | $90.301B | 1.2% | $415.43 | +3.61% | +8.85% | +3.36% | $41.35M | 17.2× |
Moderna Inc. MRNA · US | Biotechnology | $85.605B | 1.1% | $214.55 | +8.91% | +13.55% | +52.89% | $81.21M | -27.2× |
Regeneron Pharmaceuticals, Inc. REGN · US | Biotechnology | $78.688B | 1% | $749.29 | +1.31% | +1.97% | -7.53% | $9.68M | 17.8× |
The Cigna Group CI · US | Healthcare Plans | $74.447B | 1% | $282.39 | +0.48% | +5.39% | +2.38% | $9.54M | 11.6× |
Cencora Inc. COR · US | Medical Distribution | $61.66B | 0.8% | $323.12 | +0.55% | +4.31% | -0.48% | $4.86M | 23.5× |
Boston Scientific Corp. BSX · US | Medical Devices | $60.914B | 0.8% | $42.11 | +0.15% | -2.59% | -6.38% | $15.03M | 16.6× |